| Qing Wu,Shunqian Wen. Multi-disciplinary treatment for hepatocellular carcinoma in primary hospitals in China during the COVID-19 epidemic. Oncol Transl Med, 2020, 6: 233-235. |
| Multi-disciplinary treatment for hepatocellular carcinoma in primary hospitals in China during the COVID-19 epidemic |
| Received:June 10, 2020 Revised:October 16, 2020 |
| View Full Text View/Add Comment Download reader |
| KeyWord:COVID-19; primary hospital; hepatocellular carcinoma; multi-disciplinary treatment |
| Author Name | Affiliation | E-mail | | Qing Wu | Department of Hepatobiliary Surgery, Affiliated Foshan Hospital of Southern Medical University | stuwuqing@163.com | | Shunqian Wen | Department of Hepatobiliary Surgery, Affiliated Foshan Hospital of Southern Medical University | 13433123361@163.com |
|
| Hits: 6818 |
| Download times: 7662 |
| Abstract: |
| Hepatocellular carcinoma (HCC) is a common malignant tumor in the Chinese population. Due to its high
degree of malignancy, rapid progression, and poor prognosis, it mainly requires multi-disciplinary treatment
(MDT) in the clinic. In December 2019, COVID-19, a novel coronavirus pneumonia, broke out in Wuhan,
China. It has rapidly spread across the country, with various places launching a level I response to major
public health emergencies and traffic being restricted. Most patients with HCC were only able to attend
primary hospitals, while the MDT model for HCC in provincial hospitals was restricted. Therefore, it was
a huge task for clinicians in primary hospitals to ensure MDT was given to patients with HCC during the
level I response to major public health emergencies. How to formulate a reasonable MDT mode for patients
with HCC according to local conditions was worthy of consideration by hepatobiliary surgeons in primary
hospitals. |
| Close |
|
|
|